DimerixASX:DXB -5.00%32 FCF Yield % is 9.52 as of Jun. 26, 2026. GuruFocus rates ASX:DXB with a GF Score™ of 32/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Dimerix ranks better than 96.83% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Dimerix's Trailing 12-Month Free Cash Flow is A$11.43 Mil, and Market Cap is A$120.08 Mil. Therefore, Dimerix's FCF Yield % for today is 9.52%.
The historical rank and industry rank for Dimerix's FCF Yield % or its related term are showing as below:
ASX:DXB'
s FCF Yield % Range Over the Past 10 Years
Min: -4.92 Med: -2.05 Max: 42.21
Current: 9.52
During the past 13 years, the highest FCF Yield % of Dimerix was 42.21%. The lowest was -4.92%. And the median was -2.05%.
ASX:DXB's FCF Yield % is ranked better than 96.83% of 1418
companies
in the Biotechnology industry
Industry Median: -9.715
vs ASX:DXB: 9.52
Dimerix's FCF Margin % for the quarter that ended in Dec. 2025 was -1,410.68%.
Dimerix FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Dimerix FCF Yield % Related Terms
Dimerix FCF Yield % Historical Data
* Premium members only.
The historical data trend for Dimerix's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:DXB vs VRTX, REGN, ALNY: FCF Yield % Comparison
For the Biotechnology subindustry, Dimerix's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dimerix FCF Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dimerix's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Dimerix's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dimerix (ASX:DXB) has a FCF Yield % of 9.52 as of Jun. 26, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dimerix and its competitors. According to the industry distribution chart, Dimerix ranks #45 out of 1418 companies in the Biotechnology industry, placing it in the top 3.2%.
Is Dimerix's FCF Yield % too high?
Dimerix's current FCF Yield % is 9.52. Based on the distribution chart, Dimerix ranks #45 out of 1418 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dimerix has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Dimerix's FCF Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dimerix ranks #45 out of 1418 companies for FCF Yield %. This places Dimerix in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Biotechnology company?
A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Dimerix and its competitors. Dimerix's current FCF Yield % is 9.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dimerix stock overvalued right now?
Dimerix (ASX:DXB) has a current FCF Yield % of 9.52. The current FCF Yield % is 9.52. Dimerix's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Dimerix (ASX:DXB), the current FCF Yield % is 9.52 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD, as well as the proprietary ReceptorHIT assay technology. It pursues new product concepts and applies deep scientific knowledge to the discovery of products from early-stage development through to commercialisation. Dimerix products will target multiple territories. The Group has only operated in one Segment, being investment in research and development of biopharmaceutical drugs.
32GF Score
Get the complete analysis for ASX:DXB
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:DXB has been successfully added to your 
